Dr. Thomas A. Masterson, MD

Dr. Masterson practices at UMiami Medicine - Urology in Miami, Florida.

Dr. Masterson's NPI, 1629496435, was assigned on March 31, 2014. Dr. Masterson graduated from University of Miami, Miller School of Medicine in 2014. Dr. Masterson holds Florida license ME139325.

Dr. Masterson's primary practice is UMiami Medicine - Urology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Dr. Masterson's primary practice is UMiami Medicine - Urology in Miami, Florida. Dr. Masterson is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Masterson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Masterson practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Masterson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Masterson is board certified in urology by the American Board of Urology. Dr. Masterson is licensed in Florida.

Dmand AI lists erectile dysfunction, prostate inflammation or infection and urinary endoscopy among the conditions Dr. Masterson treats.

CMS data shows 38 Medicare services from Dr. Masterson across 2 procedure codes in 2024, all of them office visits, for 56 Medicare patients. Medicare paid $3,480 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Dr. Masterson in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Masterson's median patient age at 49, with 1% women.

In 2024, Dr. Masterson wrote 120 Medicare Part D claims for 48 patients. 90% of them were for generic drugs. CMS names the drug for 50 of them, across 2 drugs with 11 or more claims each, at $187 in total drug cost. In 2019, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Masterson for performance year 2024, reported as part of a group. Dr. Masterson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Masterson as offering telehealth.

Dmand AI links 55 papers to Dr. Masterson, published from 2015 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Penile Induration, Erectile Dysfunction and Penis. Dr. Masterson has published most often in Int J Impot Res. Dr. Masterson's most frequent co-authors are Ranjith Ramasamy, MD, Emad Ibrahim, MD and Quinn Carroll Rainer, Student, Healthcare.

Dmand AI links Dr. Masterson to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Erectile Dysfunction, Penile Induration and Penile Diseases. University of Miami sponsors the most, 2.

CMS Open Payments shows 227 general payments to Dr. Masterson from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Endo Pharmaceuticals Inc. paid the most, $19,664.

Dmand AI lists 5 awards for Dr. Masterson, most recently Invited to compete in the Endocrine Society’s Presidential Poster Competition for a first-authored top-scoring abstract for presentation at the Annual Meeting & Expo in 2019.

Dr. Masterson graduated from University of Miami, Miller School of Medicine in 2014. Dr. Masterson is a member of ASRM, American Urological Association and Sexual Medicine Society of North America.

Dr. Masterson is in network with 10 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.